Sort
15,440 grants matching “organoids”
Human nasal epithelial organoids as a non-invasive, personalized model for predicting effectiveness of CFTR modulators in cystic fibrosis patients
$325,403John Mellnik · Path Bioanalytics, Inc. · R41 · FY2016 · HL
Project 2 - Protein Ubiquitylation in Esophageal Cancer
$325,366J. Alan Diehl · Columbia University Health Sciences · P01 · FY2019 · CA
Targeting and DNA damage response in breast cancer
$325,339David K Cortez · Vanderbilt University Medical Center · P50 · FY2022 · CA
Targeting and DNA damage response in breast cancer
$325,338David K Cortez · Vanderbilt University Medical Center · P50 · FY2023 · CA
Elucidating the neuropathophysiology of TSC using genetically engineered human neurons
$325,252Helen S. Bateup · University Of California Berkeley · R01 · FY2017 · NS
Targeted Immunotherapeutics In Dysbiotic Microbiomes - A Feasibility and Proof-of-Concept Study
$325,139Julius G Goepp · Evimero, Llc · R43 · FY2024 · TR
HGF in Liver Development,Regeneration and Neoplasia
$325,094University Of Pittsburgh At Pittsburgh · R01 · FY2005 · CA
Project 2: Racial differences in host immune response and gastric carcinogenesis: Translating underlying biology to promote gastric cancer interception
$325,088Meira Epplein · Duke University · P20 · FY2022 · CA
Monitoring and increasing resilience of stem cell derived pancreatic islet cell grafts
$324,998Catherine Digovich · Minutia, Inc. · R43 · FY2024 · DK
Request for Dell PowerEdge XE9680 8x H100 NVIDIA GPU server
$324,955Alan Michael Watson · University Of Pittsburgh At Pittsburgh · S10 · FY2025 · OD
Replication Stress and DNA Damage Response Drives ESR1 Mutant Metastasis
$324,901Suzanne A Fuqua · Baylor College Of Medicine · R01 · FY2024 · CA
Core B - Pathology and Biospecimen Core
$324,787Sicinska · Dana-Farber Cancer Inst · P50 · FY2023 · CA
Impact of CREB-driven mechanism in shaping the tumor-immune landscape
$324,760Nagaraj S. Nagathihalli · University Of Miami School Of Medicine · R01 · FY2023 · CA
Mechanisms of resistance to endocrine therapy in ER positive breast cancer
$324,754Brent N Rexer · Vanderbilt University Medical Center · P50 · FY2023 · CA
Mechanisms of resistance to endocrine therapy in ER positive breast cancer
$324,752Carlos L Arteaga · Vanderbilt University Medical Center · P50 · FY2022 · CA
Elucidating the neuropathophysiology of TSC using genetically engineered human neurons
$324,707Helen S. Bateup · University Of California Berkeley · R01 · FY2018 · NS
Tissue-engineered Aged B Cell Immune Organoid to Study Antibody Secreting Cell Differentiation Trajectory
$324,310Ankur Singh · Georgia Institute Of Technology · R56 · FY2023 · AG
Uncovering the Role of Colorectal Stem Cells on Disease Penetrance in Lynch Syndrome
$324,218Eduardo Vilar Sanchez · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
Elucidating the neuropathophysiology of TSC using genetically engineered human neurons
$324,144Helen S. Bateup · University Of California Berkeley · R01 · FY2019 · NS
Project 2: Ex Vivo Modeling and Analysis of Gastric Precancerous Lesions
$323,829Manuel R Amieva · Stanford University · P01 · FY2025 · CA
RP-1: Defining Predictors of Sensitivity to Cisplatin-Based Chemotherapy in Urothelial Cancer
$323,676David B. Solit · Sloan-Kettering Inst Can Research · P50 · FY2024 · CA
Identification of synthetic lethal interactors in pancreatic cancer
$323,651Channing J Der · Univ Of North Carolina Chapel Hill · U01 · FY2019 · CA
Elucidating the neuropathophysiology of TSC using genetically engineered human neurons
$323,566Helen S. Bateup · University Of California Berkeley · R01 · FY2020 · NS
Core B - Molecular Pathology and Imaging Core (MPIC)
$323,503Hanina Hibshoosh · Columbia University Health Sciences · P01 · FY2020 · CA
TMPRSS2-ERG chromosomal translocations and prostate cancer
$323,262Kathleen Kelly · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA